Partnerships Based
on Experience.
Decades of it.

At Sientra, we believe that
shared expertise and values
are essential components of
success. Our leadership is driven
by decades of experience and
skill that help bring your goals
and aesthetic visions to life.

Click an Image

Jeffrey Nugent

Chairman and
Chief Executive Officer

Jeffrey Nugent’s experience includes serving as CEO and Worldwide President of Neutrogena, where he led the acquisition by Johnson & Johnson and quadrupled sales to $1B within 4 years. Neutrogena is regarded as one of the most successful acquisitions in J&J history.

Following Neutrogena, he became President and CEO of Revlon, where he led a turnaround in profitability and a global initiative of new product innovation. He overcame the significant challenge of meeting covenant commitments while moving the brands forward both in terms of revenue growth and profitability.

He was Founder, President and CEO of Precision Dermatology, a multi-channel dermatology and skin care company he established in 2010. The company grew organically and by M&A and was acquired by Valeant Pharmaceuticals for $500MM in 2013.

Mr. Nugent most recently served as Interim President, CEO and member of the Board of Directors of Biolase (Nasdaq) from 2014‐2015 following a highly contentious proxy process. Biolase is the world’s largest manufacturer and distributor of medical lasers primarily to the dental profession and a significant turnaround situation. Within three quarters, the core laser franchise returned to growth following two years of consistent decline and developed an overall 17% growth trajectory by Q2 2015.

He joined the Board of Sientra (Nasdaq) prior to its IPO in 2014 as well as Neothethics (Nasdaq) in 2015. Both are highly innovative companies in the professional aesthetic market. He also serves as an advisor and BOD member of several early stage medical and consumer product companies.

Earlier, he was a member of the Board of Bioform, (Nasdaq) prior to its sale to Merz, as well as a number of other dermatology based, medical device and consumer focused companies as CEO, Chairman and Director. He began his career at Johnson & Johnson progressing to a number of senior positions with responsibilities in General Management, Research, Marketing, Finance and Manufacturing across Pharmaceutical, Medical Device and Consumer franchises. He was appointed VP of Worldwide Quality leading an initiative of corporate competitiveness improvement reporting to the Chairman and CEO.

Mr. Nugent was a US Army officer assigned to the Central Intelligence Agency and holds an MBA in Finance and Marketing from Loyola University of Chicago and a BS in Mathematics from St. Joseph’s College.

Deborah Bettencourt

Vice President,
Customer Experience and Corporate Administration

Deborah Bettencourt joined Sientra in 2007. Ms. Bettencourt has nearly 20 years of experience in corporate operations and information technology within the medical device industry. She spent much of her professional career at Inamed Corporation (currently Allergan Medical). Ms. Bettencourt served as Director of Information Technology at Inamed Corporation where she was as an integral part of global information technology implementations, business acquisitions, system and process integrations, and international manufacturing expansions. Ms. Bettencourt is a member Society for Human Resource Management (SHRM) and holds a BA in Psychology from the University of California at Santa Barbara. Ms. Bettencourt also serves on the Board of Trustees for Marymount of Santa Barbara.

Dan Carlisle

Vice President of Product Technology and Manufacturing

Dan Carlisle joined Sientra in 2007. Mr. Carlisle has nearly 30 years of innovative product design and development experience as well as technical expertise in the aesthetic/surgical market. Prior to joining Sientra, Mr. Carlisle was Senior Director, Technical Marketing at Inamed Corporation (currently Allergan Medical) where he was responsible for designing, refining and improving new products for the global aesthetic market. Additionally, he served as Director of the internationally recognized Inamed Academy™ (currently Allergan Academy ®), a global education and training platform for surgeons. He is named inventor or co-inventor on numerous patents in the aesthetic plastic surgery field. Before Inamed, Mr. Carlisle held various management positions at Silimed Corporation based out of Brazil and at McGhan Medical. Mr. Carlisle holds a BA in Art from California State University at Northridge.

Rosalyn d’Incelli

Vice President, Clinical Operations

Rosalyn d’Incelli joined Sientra in 2009. Ms. d’Incelli has more than 13 years of Clinical Research experience coupled with an accomplished record of clinical achievements. Prior to joining Sientra, she was the Director of Clinical Studies at Mentor Corporation, where she oversaw many of the company’s studies and managed their clinical resources. Ms. d’Incelli was a significant contributor to Mentor’s successful Silicone-Gel PMA approval, and at the time led the company’s large Post-Approval Silicone-Gel study. Additionally, she served as Clinical Director for Mentor’s phase 3 botulinum toxin studies and was previously involved in multiple urology studies. Prior to joining Mentor, Ms. d’Incelli was employed at Inamed Corporation (currently Allergan Medical) in Clinical Operations where she was a member of the clinical study team seeking approval for the company’s Silicone-Gel PMA. She has a demonstrated successful track record in the area of clinical operations with notable clinical studies completions in the areas of Breast and Facial Aesthetics and marketing approvals. Ms. d’Incelli holds a BA from the University of California Santa Barbara and is SoCRA board certified in Clinical Research.

JoAnn Kuhne

Vice President Regulatory Affairs and Quality Assurance

JoAnn Kuhne joined Sientra in 2006. Ms. Kuhne has more than twenty years of global regulatory and clinical experience. Prior to joining Sientra, Ms. Kuhne served as Senior Director, Regulatory Affairs at Inamed Corporation (now Allergan Medical) where she was instrumental in the company’s efforts to obtain PMA approval for the company’s silicone gel breast implants. Before Inamed, Ms. Kuhne was Director of Regulatory & Clinical Affairs at Medtronic PS Medical, leading the company’s global regulatory and clinical efforts for its neurosurgical implants. Preceding her career at Medtronic PS Medical and Inamed, Ms. Kuhne spent several years in the orthopedic implant industry as Manager of Regulatory Affairs for Smith and Nephew Orthopedics and Intermedics Orthopedics. Ms. Kuhne received her BSN from Northern Michigan University in Marquette, Michigan and an MSN from the University of North Carolina at Chapel Hill. She is a member of the Sigma Theta Tau International Honor Society and is board certified in Regulatory Affairs. Ms. Kuhne is an active volunteer at the Santa Ynez Valley Therapeutic Riding Center and is a sponsor for Threshold Ministries and Impact 2818.

Rich Low

Vice President of Marketing

Rich Low brings more than 17 years of experience in the aesthetic medicine industry to Sientra. Prior to joining Sientra, Mr. Low held senior positions at Mentor Corporation WW LLC, a division of Johnson & Johnson, where he was responsible for a wide variety of upstream and downstream marketing initiatives in the plastic surgery and non-surgical markets including new technology development and market creation. Mr. Low has introduced a significant number of new products to the aesthetic surgical market including top-selling breast implants and breast tissue expanders. Additionally, he led the introduction of new injectable products to Europe, Latin America, Canada, and Asia, and topical skin care treatments in the US. Mr. Low holds an MBA from the Anderson School of Management at UCLA, an undergraduate degree from UC Riverside with a year of undergraduate work at Victoria University in Wellington, New Zealand. Mr. Low is on the Board of Directors of the Immune Deficiency Foundation which works to raise funds and awareness for people born with primary immune deficiencies.

Jason O’Hearn

Vice President of Sales

Jason O’Hearn brings more than 18 years of aesthetic medical device experience to Sientra, 10 of those years were spent in senior/executive management positions. Prior to joining Sientra, Mr. O’Hearn was Vice President of Sales at Mentor Corporation WW LLC, a division of Johnson & Johnson. He was responsible for leading a team of approximately 110 sales professionals and his efforts resulted in Mentor becoming a world leader in breast implant sales. Mr. O’Hearn played a vital role in the introduction and acceptance of silicone gel implants into the U.S. market, and he has demonstrated a successful track record of moving market share in a highly competitive market. Mr. O’Hearn holds BA in Business Management and a minor in Finance from San Diego State University. Mr. O’Hearn is a volunteer for the Mesa Beautification Committee, which raises funds and awareness on how to keep our Santa Barbara beaches and parks clean.

Matt Pigeon

Chief Financial Officer and Treasurer

Matt Pigeon joined Sientra in 2010. Mr. Pigeon has strong financial and operating capabilities with more than 15 years of investment banking experience. Prior to joining Sientra, Mr. Pigeon served as Chief Financial Officer and Chief Strategy Officer for FRS Healthy Energy, a functional beverage company. At FRS, he led all finance, accounting and reporting, including the funding efforts that successfully resulted in completing Series A and B preferred rounds led by Oak Investment Partners. Before FRS Healthy Energy, Mr. Pigeon was a Principal at Banc of America Securities/Montgomery Securities and served in both the equity capital markets group and investment banking group. While at Banc of America Securities, he was focused on multiple sectors including Consumer Products, Media & Telecommunications, Technology and Real Estate. Mr. Pigeon was responsible for the origination and execution of public and private equity transactions, convertible debt, structured products, and mergers and acquisitions. He also provided senior management teams and board of directors with structuring and execution advisory services to achieve an extensive array of financing goals including acquisition capital, de-leveraging, restructuring, and growth capital. Mr. Pigeon received his B.A. degree from the University of California at Santa Barbara and his MBA from the University of Southern California. Mr. Pigeon currently serves on the Board of Directors for Elings Park, Santa Barbara.

Charlie Huiner

Chief Strategy and Corporate Development Officer

Charlie Huiner joined Sientra in 2014 and brings with him a successful track record of more than 20 years in business development, marketing and strategy, where, in the past 11 years, he served in senior roles in the medical technology and device industries. Mr. Huiner's medical device and aesthetics experience includes 3 years at INAMED (now Allergan Medical) where, as Senior Director of Corporate Development and Strategy, his responsibilities spanned business development, strategy, corporate communications and investor relations. At INAMED, Mr. Huiner served a core role in a number of important partnership and in-licensing transactions including the acquisition of JUVÉDERM®, and he was also part of the senior transaction team that executed the $3.3 billion sale of INAMED to Allergan Medical. Immediately prior to joining Sientra, Mr. Huiner was at InTouch Health where he served as Vice President of Business Development and Marketing. At InTouch Health, he led a number of important strategic growth initiatives including conceiving of, building, and leading the Company's B-to-B surgical collaboration business. His extensive transactional and strategy transformation expertise is grounded by early career experience in operating and investing roles with Security Capital Group (now GE Capital) and ProLogis Trust. He began his career as an M&A financial analyst for NatWest Bancorp. Mr. Huiner earned a BA in History from Williams College, and an MBA in finance and marketing from Northwestern University's Kellogg School where he concentrated in healthcare management.